コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 23 degrees C) (i.e. 10-20 times faster than N-ethylmaleimide).
2 ysteines by oxidation and reaction with NEM (N-ethylmaleimide).
3 y blocking the S-nitrosylation reaction with N-ethylmaleimide.
4 nd to be predominantly modified by thiols or N-ethylmaleimide.
5 ide-sensitive factor attachment protein, and N-ethylmaleimide.
6 S-nitrosoglutathione, hydrogen peroxide, or N-ethylmaleimide.
7 reatment of cells with low concentrations of N-ethylmaleimide (10 microM), suggesting that enrichment
13 ne residues to the membrane-permeant reagent N-ethylmaleimide and the membrane-impermeant reagent pol
15 hibited by sodium vanadate, sodium fluoride, N-ethylmaleimide, and phenylglyoxal but was not signific
16 nt species are trapped by cycloaddition with N-ethylmaleimide, and the reactions are traced by high r
17 have been shown to be covalently modified by N-ethylmaleimide, and this treatment was found to block
18 ions for activity, was potently inhibited by N-ethylmaleimide, and was labile at temperatures above 4
20 al calcium-dependent Syt1 binding to soluble N-ethylmaleimide attachment protein receptor (SNARE) and
21 tion of Gbetagamma subunits with the soluble N-ethylmaleimide attachment protein receptor (SNARE) com
22 Although FAK inhibition decreased soluble N-ethylmaleimide attachment protein receptor (SNARE)-med
23 6, a Golgi-localized target membrane-soluble N-ethylmaleimide attachment protein receptor (t-SNARE) p
24 lent modification of its free cysteines with N-ethylmaleimide blocked binding to UL11 but not UL21.
25 y the membrane-permeable sulfhydryl blocker, N-ethylmaleimide, by the RGD peptide, and by anti-alphaI
28 ined the role of a vesicle-residing, soluble N-ethylmaleimide factor attachment protein receptor (v-S
29 r semolina protein (g protein) or 13.8 mumol N-ethylmaleimide/g protein reduces gliadin-glutenin cros
31 of the completely conserved Cys353) through N-ethylmaleimide modification or mutagenesis to alanine
32 ble redox states of both the as purified and N-ethylmaleimide-modified forms, using the combination o
33 tment of muscle cells with the NSF inhibitor N-ethylmaleimide, mutation of NSF, or suppression of NSF
37 we have investigated the mechanism by which N-ethylmaleimide (NEM) enhances transporter activity usi
38 n erythrocytes, the cysteine-modifying agent N-ethylmaleimide (NEM) has been shown to inhibit system
39 ng of the protein thiol groups on the MPI by N-ethylmaleimide (NEM) markedly reduced this rate consta
40 ions isolated in the presence and absence of N-ethylmaleimide (NEM), a chemical that reacts irreversi
41 e rate and effect of Cys-159 modification by N-ethylmaleimide (NEM), a cysteine-selective alkylating
42 pyridine, a known Isomerase I inhibitor, and N-ethylmaleimide (NEM), a known LRAT inhibitor, signific
43 ced unfolding (CIU), chemical labeling using N-ethylmaleimide (NEM), and both bottom-up and top-down
45 nalytes ((310)GSH and (616)GSSG), along with N-ethylmaleimide (NEM), and treated with acetonitrile to
46 was cGMP independent but could be blocked by N-ethylmaleimide (NEM), indicating that NO acted via an
50 were more modest with a slight inhibition in N-ethylmaleimide (NEM, 1 mm)-treated RBCs and stimulatio
51 e current generated by the alkylating agent, N-ethylmaleimide, occluded the effect of H(2)O(2) The H(
52 by (2-aminoethyl)-methane thiosulfonate and N-ethylmaleimide of cysteine mutant proteins were measur
53 chemical labeling by isotope-coded forms of N-ethylmaleimide or succinic anhydride to site-specifica
54 ydes (c = 8 mmol L(-1)), photoligations with N-ethylmaleimide (possible for lambda </= 390 nm) are id
55 above their optimums and by Ca(2+), Zn(2+), N-ethylmaleimide, propranolol, and the sphingoid bases s
56 inganine) lipids, nucleotides (ATP and CTP), N-ethylmaleimide, propranolol, phenylglyoxal, and divale
59 ically inhibits NSF/Sec18 activity than does N-ethylmaleimide, requiring the administration of only l
62 e release machinery, this assay incorporates N-ethylmaleimide sensitive factor (NSF) and alpha-SNAP,
63 olecule binds our two model His(6) proteins, N-ethylmaleimide sensitive factor (NSF) and O(6)-alklygu
64 Moreover, we provided evidence for a role of N-ethylmaleimide sensitive factor (NSF) in regulating Mu
65 y related to the single N domains in p97 and N-ethylmaleimide sensitive factor (NSF); N1 of Pex1 is m
67 ction, enabling cooperation with the soluble N-ethylmaleimide sensitive factor adaptor protein recept
68 t significantly reduced formation of soluble n-ethylmaleimide sensitive factor adaptor protein recept
71 tinct combinations of Munc18 and the soluble N-ethylmaleimide sensitive factor attachment protein rec
74 his study identifies the function of soluble N-ethylmaleimide sensitive factor attachment protein rec
75 rt a role for tethering complexes in soluble N-ethylmaleimide sensitive factor attachment protein rec
76 domain, which likely participates in soluble N-ethylmaleimide sensitive factor attachment protein rec
77 study pinpoints the pivotal role of soluble N-ethylmaleimide sensitive factor attachment protein rec
78 gmin, complexin, and neuronal SNARE (soluble N-ethylmaleimide sensitive factor attachment protein rec
80 taining lipid bilayers as well as to soluble N-ethylmaleimide sensitive factor receptors (SNAREs) and
85 requires membrane fusion mediated by soluble N -ethylmaleimide-sensitive factor (NSF) attachment prot
87 by the packaging of a SNARE protein (soluble N-ethylmaleimide-sensitive attachment protein receptor)
88 vity to tomosyn that are outside the soluble N-ethylmaleimide-sensitive attachment receptor motif.
89 ty on secretion without altering its soluble N-ethylmaleimide-sensitive attachment receptor pairing w
90 18-1 (stabilizes assembled SNARE complexes), N-ethylmaleimide-sensitive factor (NSF) (disassembles SN
92 ly AAA domain-containing protein 1), soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote
94 t is directly involved in regulating soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote
95 domain and modulate the affinity for soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote
96 isoforms to directly regulate SNARE (soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote
101 daptor molecule for the SNARE-priming enzyme N-ethylmaleimide-sensitive factor (NSF) is known to be c
102 novel synaptic interaction between Arr1 and N-ethylmaleimide-sensitive factor (NSF) that is enhanced
103 inhibits exocytosis by chemically modifying N-ethylmaleimide-sensitive factor (NSF), a key component
104 n kinase Cepsilon (PKCepsilon) regulates the N-ethylmaleimide-sensitive factor (NSF), an ATPase criti
105 s hepatic secretion of VLDL-TAG by targeting N-ethylmaleimide-sensitive factor (NSF), both in vivo an
107 cate a core complex of proteins comprised of N-ethylmaleimide-sensitive factor (NSF), soluble NSF att
110 diverse cellular activities (AAA+) protein, N-ethylmaleimide-sensitive factor (NSF/Sec18), and its c
111 ents, whereas further incubation with p97 or N-ethylmaleimide-sensitive factor (two AAA ATPases invol
112 e presence of LPC as opposed to cholesterol, N-ethylmaleimide-sensitive factor + adenosine triphospha
113 sively to the predicted syntaxin and soluble N-ethylmaleimide-sensitive factor accessory protein rece
114 cer to prevent the completion of the soluble N-ethylmaleimide-sensitive factor activating protein rec
115 lar C-terminus domain and the SNARE (soluble N-ethylmaleimide-sensitive factor activating protein rec
117 am of the Rab GTPase Sec4 to promote soluble N-ethylmaleimide-sensitive factor adaptor protein recept
118 or of the Sec4 Rab GTPase to promote soluble N-ethylmaleimide-sensitive factor adaptor protein recept
119 amined whether genetic disruption of soluble N-ethylmaleimide-sensitive factor attached protein (SNAR
121 cognate acceptor compartments before soluble N-ethylmaleimide-sensitive factor attachment protein (SN
122 The assembly of the three neuronal soluble N-ethylmaleimide-sensitive factor attachment protein (SN
124 SNARE) complexes in conjunction with soluble N-ethylmaleimide-sensitive factor attachment protein (SN
125 a (SNAP-25) is a key molecule in the soluble N-ethylmaleimide-sensitive factor attachment protein (SN
126 his study, we identify the vesicular soluble N-ethylmaleimide-sensitive factor attachment protein rec
127 ular machines that are essential for soluble N-ethylmaleimide-sensitive factor attachment protein rec
128 cellular transport vesicles requires soluble N-ethylmaleimide-sensitive factor attachment protein rec
129 h abnormal expression or function of soluble N-ethylmaleimide-sensitive factor attachment protein rec
131 vitro by arresting the late steps of soluble N-ethylmaleimide-sensitive factor attachment protein rec
132 o an open conformation to accelerate soluble N-ethylmaleimide-sensitive factor attachment protein rec
133 transmitters and hormones depends on soluble N-ethylmaleimide-sensitive factor attachment protein rec
134 se from beta-cells, specifically the soluble N-ethylmaleimide-sensitive factor attachment protein rec
135 mice expressing a dominant-negative soluble N-ethylmaleimide-sensitive factor attachment protein rec
136 Neuronal exocytosis is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec
140 ent work suggested that ER-localized soluble N-ethylmaleimide-sensitive factor attachment protein rec
141 is depends on efficient formation of soluble N-ethylmaleimide-sensitive factor attachment protein rec
144 erved increase in K(+) currents is a soluble N-ethylmaleimide-sensitive factor attachment protein rec
146 tether at the plasma membrane before soluble N-ethylmaleimide-sensitive factor attachment protein rec
147 aptic vesicles, including the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
148 thaliana, include complexes, such as soluble N-ethylmaleimide-sensitive factor attachment protein rec
149 litate the formation of trans-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
150 etric levels with its cognate target-soluble N-ethylmaleimide-sensitive factor attachment protein rec
151 rs in membrane fusion events are the soluble N-ethylmaleimide-sensitive factor attachment protein rec
153 es depends on the disassembly of cis-soluble N-ethylmaleimide-sensitive factor attachment protein rec
154 ter release and vesicle recycling in soluble N-ethylmaleimide-sensitive factor attachment protein rec
155 UT4 vesicle fusion reaction requires soluble N-ethylmaleimide-sensitive factor attachment protein rec
156 organelles involves the formation of soluble N-ethylmaleimide-sensitive factor attachment protein rec
157 ructural relationships among SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec
158 at Munc18c binds to the trans-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
159 n fusogens from vesicle trafficking (soluble N-ethylmaleimide-sensitive factor attachment protein rec
160 sis requires the concerted action of soluble N-ethylmaleimide-sensitive factor attachment protein rec
161 existence of the unproductive target soluble N-ethylmaleimide-sensitive factor attachment protein rec
162 proteins are important components of soluble N-ethylmaleimide-sensitive factor attachment protein rec
164 insulin granules, is carried out by soluble N-ethylmaleimide-sensitive factor attachment protein rec
167 Platelet exocytosis is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec
168 of the fusion pore induced by SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
170 ere is comparable fusion of 4-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
171 he general membrane fusion machinery-soluble N-ethylmaleimide-sensitive factor attachment protein rec
172 f exocytosis by interacting with the soluble N-ethylmaleimide-sensitive factor attachment protein rec
173 ey synaptic proteins from the soluble SNARE (N-ethylmaleimide-sensitive factor attachment protein rec
174 v2.1 is postulated to be involved in soluble N-ethylmaleimide-sensitive factor attachment protein rec
175 icle marker proteins, glutamate, the soluble N-ethylmaleimide-sensitive factor attachment protein rec
177 labeled vesicle-associated v-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
179 st that syt1 might facilitate SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
181 mediated by the formation of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
182 ric syntaxin 1A, and it can activate soluble N-ethylmaleimide-sensitive factor attachment protein rec
183 between subsets of so-called SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
184 e Arabidopsis (Arabidopsis thaliana) soluble N-ethylmaleimide-sensitive factor attachment protein rec
185 Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein rec
186 -overexpression of ER/Golgi arginine soluble N-ethylmaleimide-sensitive factor attachment protein rec
187 ed components: vacuolar lipids, four soluble N-ethylmaleimide-sensitive factor attachment protein rec
189 udies of membrane fusion mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec
190 wo C2 domains, and the neuronal core soluble N-ethylmaleimide-sensitive factor attachment protein rec
191 oteins that regulate the activity of soluble N-ethylmaleimide-sensitive factor attachment protein rec
192 usion is mediated by the concerted action of N-ethylmaleimide-sensitive factor attachment protein rec
194 activity on one of the three SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
195 ces derived from target- and vesicle-soluble N-ethylmaleimide-sensitive factor attachment protein rec
196 icularly involving small G proteins, soluble N-ethylmaleimide-sensitive factor attachment protein rec
197 ia a Gbetagamma interaction with the soluble N-ethylmaleimide-sensitive factor attachment protein rec
198 c1/Munc18 (SM) proteins bind cognate soluble N-ethylmaleimide-sensitive factor attachment protein rec
199 and botulinum neurotoxin C to cleave soluble N-ethylmaleimide-sensitive factor attachment protein rec
200 with purified yeast vacuolar SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec
202 mitter release requires three SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
203 ade transport of the plasma membrane soluble N-ethylmaleimide-sensitive factor attachment protein rec
204 otulinum neurotoxins cleave specific soluble N-ethylmaleimide-sensitive factor attachment protein rec
205 a do not contain the t-SNARE (target-soluble N-ethylmaleimide-sensitive factor attachment protein rec
206 on and vacuole protein sorting), and soluble N-ethylmaleimide-sensitive factor attachment protein rec
208 -mediated selective concentration of soluble N-ethylmaleimide-sensitive factor attachment protein rec
209 2Delta) for the Tlg2 target membrane-soluble N-ethylmaleimide-sensitive factor attachment protein rec
211 binds to and cleaves syntaxin 17, a soluble N-ethylmaleimide-sensitive factor attachment protein rec
212 by specific fusion proteins [such as soluble N-ethylmaleimide-sensitive factor attachment protein rec
213 unc13-4 is a Ca(2+)-dependent SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
214 ily GTPases, their effector tethers, soluble N-ethylmaleimide-sensitive factor attachment protein rec
217 y and activation of (phago)lysosomal soluble N-ethylmaleimide-sensitive factor attachment protein rec
218 brane protein 4 (VAMP4), a vesicular soluble N-ethylmaleimide-sensitive factor attachment protein rec
219 which, in turn, interacts with the lysosomal N-ethylmaleimide-sensitive factor attachment protein rec
222 n vitro and to separate the roles of soluble N-ethylmaleimide-sensitive factor attachment protein rec
224 nal by cooperating with the neuronal soluble N-ethylmaleimide-sensitive factor attachment protein rec
225 er release requires the formation of soluble N-ethylmaleimide-sensitive factor attachment protein rec
226 11 interact with the vacuolar SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec
228 nner with syntaxin-3 and syntaxin-1A soluble N-ethylmaleimide-sensitive factor attachment protein rec
229 a component of the synaptic vesicle soluble N-ethylmaleimide-sensitive factor attachment protein rec
232 stituted with the target (t)-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec
233 loit a polarized distribution of the soluble N-ethylmaleimide-sensitive factor attachment protein rec
234 gue Dawley rats, 4 dominant-negative soluble N-ethylmaleimide-sensitive factor attachment protein rec
235 iated by the formation of functional soluble N-ethylmaleimide-sensitive factor attachment protein rec
236 s the Rab GTPase Ypt7p, four SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec
237 guanosine 5'-3-O-(thio)triphosphate, soluble N-ethylmaleimide-sensitive factor attachment protein, an
238 nt protein receptor (SNARE) proteins soluble N-ethylmaleimide-sensitive factor attachment protein-25
239 02590 (a predicted alpha-SNAP [alpha-soluble N-ethylmaleimide-sensitive factor attachment protein]).
240 role of the fusion proteins, SNAREs (soluble N-ethylmaleimide-sensitive factor attachment proteins),
241 osine triphosphate-binding proteins, soluble N-ethylmaleimide-sensitive factor attachment proteins, a
243 ocytosis relies on assembly of three soluble N-ethylmaleimide-sensitive factor attachment receptor (S
244 lysosomes for degradation following soluble N-ethylmaleimide-sensitive factor attachment receptor (S
246 Syntaxin 1a is a plasma membrane soluble N-ethylmaleimide-sensitive factor attachment receptor pr
247 ions homologous to eukaryotic SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor) d
248 Syt 1 using a reconstituted, SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor)-m
249 of tail-anchored proteins, including soluble N-ethylmaleimide-sensitive factor attachment receptors (
250 ndence in the NSF gene, encoding the protein N-Ethylmaleimide-Sensitive Factor essential for synaptic
251 hibiting the binding of SNAREs to Sec18p, an N-ethylmaleimide-sensitive factor homologue responsible
252 Using the trimerized alphaSNAP, we find that N-ethylmaleimide-sensitive factor hydrolyzes 10 ATP mole
254 ane-resident syntaxin-like glutamine-soluble N-ethylmaleimide-sensitive factor protein attachment pro
255 P2;5 are regulated by the SNARE (for soluble N-ethylmaleimide-sensitive factor protein attachment pro
258 RE complex is disassembled by the AAA-ATPase N-ethylmaleimide-sensitive factor that requires the cofa
260 , an essential component of the soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein re
262 SF attachment protein, and NSF is defined as N-ethylmaleimide-sensitive factor) complexes catalyze sy
263 e SNARE bundles are reactivated by hexameric N-ethylmaleimide-sensitive factor, vesicle-fusing ATPase
265 structures, and here we examine the role of N-ethylmaleimide-sensitive factor-activating protein rec
266 gral membrane transporters, ATPases, soluble N-ethylmaleimide-sensitive factor-activating protein rec
267 During synaptic vesicle fusion, the soluble N-ethylmaleimide-sensitive factor-attachment protein rec
269 ogenetic approach to identify target soluble N-ethylmaleimide-sensitive factor-attachment protein rec
272 uscular synapses through cleavage of soluble N-ethylmaleimide-sensitive fusion (NSF) attachment prote
273 he NT-CT interaction is further disrupted by N-ethylmaleimide-sensitive fusion ATPase (NSF), which as
274 rement of Ca(2+) for the assembly of soluble N-ethylmaleimide-sensitive fusion attachment protein rec
275 vesicle (DCV) exocytosis is a SNARE (soluble N-ethylmaleimide-sensitive fusion attachment protein rec
276 rylates SNAP-23, the target membrane soluble N-ethylmaleimide-sensitive fusion factor attachment prot
277 We identified a direct interaction between N-ethylmaleimide-sensitive fusion protein (NSF), an ATPa
280 by integral membrane proteins called soluble N-ethylmaleimide-sensitive fusion protein attachment pro
282 Membrane associated proteins SNAREs (soluble N-ethylmaleimide-sensitive fusion protein attachment pro
284 ons between synaptotagmin and SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment rec
285 , dependent on GluA2 not GluA1, sensitive to N-ethylmaleimide-sensitive fusion protein interaction, a
286 ns and specific cleavage of neuronal soluble N-ethylmaleimide-sensitive fusion protein-attachment pro
287 vesicles in the brain harbor several soluble N-ethylmaleimide-sensitive-factor attachment protein rec
288 rtery ECs, depletion of Galpha12 and soluble N-ethylmaleimide-sensitive-fusion factor attachment prot
290 ce, glutathione was derivatized in-situ with N-ethylmaleimide to block the cysteine residue and to en
291 ing of untreated, Cytochalasin B treated and N-Ethylmaleimide treated MCF-7 breast cancer cells demon
294 s either functionally impaired by trypsin or N-ethylmaleimide treatments or with protein-free liposom
295 the nonspecific small molecule DUB inhibitor N-ethylmaleimide was 16.2+/-3.2 muM and can be used as a
297 -aminoethyl methanethiosulfonate, but not by N-ethylmaleimide, was fully protected in the presence of
298 by the kinase inhibitor staurosporine and by N-ethylmaleimide, whereas KCC2(WT), KCC2(T934A), and KCC
299 ation of its only free cysteine residue with N-ethylmaleimide), which causes significant reduction in
300 with either 20mM added NaCl (WPI+NaCl), 5mM N-ethylmaleimide (WPI+NEM) or 20mM added NaCl and 5mM NE